Provided by Tiger Trade Technology Pte. Ltd.

DexCom

84.32
+0.44000.52%
Volume:598.38K
Turnover:50.15M
Market Cap:31.82B
PE:33.24
High:84.58
Open:83.27
Low:82.29
Close:83.88
52wk High:92.59
52wk Low:54.11
Shares:377.36M
Float Shares:376.00M
Volume Ratio:0.58
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.54
EPS(LYR):2.09
ROE:38.49%
ROA:10.33%
PB:12.14
PE(LYR):40.35

Loading ...

Movement Alert|DexCom Rises 6.28% in After-Hours Trading, Q2 Earnings and Revenue Beat Expectations with Full-Year Guidance Raised

Market Focus
·
Jul 31

Stock Track | DexCom Soars 5.98% After-Hours on Q2 Earnings Beat and Upgraded 2026 Outlook

Stock Track
·
Jul 31

Dexcom Reports Higher Profit, Raises FY Sales Outlook

Dow Jones
·
Jul 31

DexCom Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance

MT Newswires Live
·
Jul 31

DexCom reports Q2 EPS 70c, consensus 61c

TIPRANKS
·
Jul 31

DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B

TIPRANKS
·
Jul 31

GUIDANCE: (DXCM) DexCom Expects Full Year 2026 Revenue Range $5.18B - $5.25B, vs. FactSet Est of $5.22B

MT Newswires Live
·
Jul 31

Dexcom Q2 FY26 GAAP Net Income Rises 39% to $249.1 Million; Revenue Climbs 13% to $1.31 Billion

Reuters
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Dexcom Inc Shares Rise 4.7% After the Bell Following Results

THOMSON REUTERS
·
Jul 31

Dexcom Shares Rise 4.6% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.61

Reuters
·
Jul 31

DexCom Q2 Adj. EPS $0.70 Beats $0.61 Estimate, Sales $1.308B Beat $1.290B Estimate

Benzinga Earnings
·
Jul 31

Dexcom Outlook FY Revenue USD 5,180-5,250 Million

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted Gross Profit USD 838.5 Million

THOMSON REUTERS
·
Jul 31

DexCom options imply 6.7% move in share price post-earnings

TIPRANKS
·
Jul 31

Alert from Law Firm on DexCom Withdrawn

Reuters
·
Jul 29

Did Dexcom, Inc. Insiders Breach Their Fiduciary Duties to Shareholders?

THOMSON REUTERS
·
Jul 29

DexCom Price Target Announced at $96.00/Share by UBS

Dow Jones
·
Jul 29

UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating

MT Newswires Live
·
Jul 28